TYRATECH, INC. 22 April 2015
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified on 21 April 2015, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 555,780 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 5.14 pence per TyraTech share.
Mr & Mrs Reade then immediately repurchased 588,740 Common shares at 5.15 pence per TyraTech share; these shares being acquired equally into their respective ISA accounts.
Following these transactions, Alan Reade's beneficial interest in the Company has increased by 32,960 TyraTech shares to 12,733,616 TyraTech shares representing approximately 4.87% of the Company's issued share capital.
For further information please contact:
|
TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer Vincent T. Morgus, Chief Financial Officer & Treasurer | Tel: +1 919 415 4340 Tel: +1-919-415-4287 |
|
SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3552 Tel: +44203 368 3551 |
|
Allenby Capital Limited , Joint Broker Chris Crawford | Tel: +44 20 3328 5656 |
|
Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins | Tel: +44 20 7659 1240 |
|
Walbrook, Financial PR and IR Nick Rome/ Guy McDougall | Tel: +44 20 7933 8790 |
|
distributed by
|
